EAM

During the course of the past 40 years, we have launched and developed five highly-respected journals, which largely fund our charitable activities. This includes our grants programme, biennial congress, and the European Academy of Microbiology (EAM).

The EAM is a leadership group of around 150 eminent microbiology experts who came together in 2009 to amplify the impact of microbiology and microbiologists in Europe.

Past activities

Year EAM’s Key initiatives 
2011 Article – the enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak
2011 Workshop – participation at the FEMS Congress 2011 included a 2 hour EAM/EMF-led Keynote Lecture and Roundtable Discussion on “Emerging Diseases — Pandemics, Drug Resistance and Vaccines”
2012 Seminar – a seminar addressing Coinfections was hosted by the European Academy of Microbiology (EAM) and the German National Academy of Sciences in Leopoldina. Ten speakers presented.  A Special Edition ‘Co-infections’ was produced by the EAM and EMF in FEMS Journal Pathogens and Disease. It included a total of 10 x mini reviews / research articles.
2013 Workshop – Infection Diagnostics and Infection Biology
2014 Workshop – a retreat workshop with a number of presentations
2015 Special event – at FEMS 2015, EAM chaired the special event ‘Microbiome and human health’
2016 Workshop – a retreat workshop with a number of presentations
2017 Workshop – at FEMS2017, EAM chaired a workshop ‘Bacterial Survival Strategies’
2018 Workshop – a retreat workshop with a number of presentations
Featured article

Induced erythromycin resistance promotes solithromycin resistance in S. aureus

The aim of this study was to determine whether in vitro induced erythromycin resistance facilitates the cross-resistance to the novel fluoroketolide, solithromycin, in Staphylococcus aureus. Long-term exposure of erythromycin results in resistance to ketolides in S. aureus through drug binding site mutations. These results demonstrate that since erythromycin has been used clinically for a long time, it is necessary to carefully evaluate the rewards and risks when prescribing solithromycin for the treatment of infectious diseases.

read more
More articles
more articles